Single-cell analysis characterizes PLK1 as a promoter of immunosuppressive tumor microenvironment in LUAD
Kong, Y.; Li, C.; Liu, J.; Zhang, M.; Allison, D. B.; Hassan, F.; He, D.; Wang, X.; Mao, F.; Zhang, Q.; Zhang, Y.; Li, Z.; Wu, S.; Wang, C.; Liu, X.
Show abstract
PLK1 (Polo-like kinase 1) plays a critical role in the progression of lung adenocarcinoma (LUAD). Recent studies have unveiled that targeting PLK1 improves the efficacy of immunotherapy, highlighting its important role in the regulation of tumor immunity. Nevertheless, our understanding of the intricate interplay between PLK1 and the tumor microenvironment (TME) remains incomplete. Here, using genetically engineered mouse model and single-cell RNA-seq analysis, we report that PLK1 promotes an immunosuppressive TME in LUAD, characterized with enhanced M2 polarization of tumor associated macrophages (TAM) and dampened antigen presentation process. Mechanistically, elevated PLK1 coincides with increased secretion of CXCL2 cytokine, which promotes M2 polarization of TAM and diminishes expression of class II major histocompatibility complex (MHC-II) in professional antigen-presenting cells. Furthermore, PLK1 negatively regulates MHC-II expression in cancer cells, which has been shown to be associated with compromised tumor immunity and unfavorable patient outcomes. Taken together, our results reveal PLK1 as a novel modulator of TME in LUAD and provide possible therapeutic interventions.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells 94%
- High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate theprogression of pancreatic cancer 94%
- Single-cell Transcriptome Profiling of Post-treatment and Treatment-naive Colorectal Cancer: Insights into Putative Mechanisms of Chemoresistance 94%
Similar papers in this journal
- PMAIP1-Mediated Glucose Metabolism and its Impact on the Tumor Microenvironment in Breast Cancer: Integration of Multi-Omics Analysis and Experimental Validation 94%
- A 'one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer 94%
- ORMDL1 is upregulated and associated with favorable outcome in colorectal cancer 94%
Similar papers in this journal
- Single-cell transcriptome analysis of the immunosuppressive effect of differential expression of tumor PD-L1 on responding TCR-T cells 96%
- The immune landscape of primary central nervous system diffuse large B cell lymphoma 94%
- The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities 93%
Similar papers in this journal
- NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model 96%
- Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway 95%
- Single-cell Sequencing Highlights Heterogeneity and Malignant Progression in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma 95%
Similar papers in this journal
- Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma 95%
- Androgen Receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR 93%
- Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+ T cells to suppress anti-tumor immunity 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.